SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sheng-Shun Yang, Jia-Horng Kao, Asunaprevir-containing regimens for the treatment of hepatitis C virus infection, Expert Review of Gastroenterology & Hepatology, 2015, 9, 1, 9

    CrossRef

  2. 2
    Muneshige Shiraishi, Itsuro Umebayashi, Hiroaki Matsuda, Keisuke Sawamura, Aiko Okada, Masako Karino, Yoshihide Nogami, Postmarketing surveillance of telaprevir-based triple therapy for chronic hepatitis C in Japan, Hepatology Research, 2015, 45, 8
  3. 3
    Goki Suda, Yoshiya Yamamoto, Astushi Nagasaka, Ken Furuya, Mineo Kudo, Yoshimichi Chuganji, Yoko Tsukuda, Seiji Tsunematsu, Fumiyuki Sato, Katsumi Terasita, Masato Nakai, Hiromasa Horimoto, Takuya Sho, Mitsuteru Natsuizaka, Kouji Ogawa, Shunsuke Ohnishi, Makoto Chuma, Yasuyuki Fujita, Riichiro Abe, Miki Taniguchi, Mina Nakagawa, Yasuhiro Asahina, Naoya Sakamoto, Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions, Hepatology Research, 2015, 45, 8
  4. 4
    Brigitte Milpied-Homsi, Ellen M. Moran, Elizabeth J. Phillips, Antiviral Drug Allergy, Immunology and Allergy Clinics of North America, 2014, 34, 3, 645

    CrossRef

  5. 5
    Akiko Kishi, Nobukazu Hayashi, Kuniaki Ohara, Keiji Aoki, Ichimaro Yamada, Kenji Ikeda, Hiromitsu Kumada, Biphasic skin reactions during telaprevir-based therapy of Japanese patients infected with hepatitis C virus, Journal of the American Academy of Dermatology, 2014, 70, 3, 584

    CrossRef

  6. 6
    Isobel D. Ramsay, Jodi M. Lestner, Catherine P. O’Sullivan, Ana L.G. Cruz, Ho Kwong Li, Charlotte I.S. Barker, A worldwide yearly survey of new data in adverse drug reactions, 2014,

    CrossRef